NAIROBI, Nov. 24 (Xinhua) -- Thirteen African countries on Tuesday announced a collaborative venture with international research networks to implement clinical trials aimed at enhancing treatment of mild COVID-19 cases.
The Drugs for Neglected Diseases Initiative (DNDi), an international drugs research entity, said in a statement released in Nairobi that the clinical trials will be conducted in 19 sites to help identify therapeutics that could prevent COVID-19 patients from reaching critical stages.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
